Andrea Biffi
Director/Board Member bei ASENSUS SURGICAL, INC.
Vermögen: 454 209 $ am 31.03.2024
Profil
Mr. Andrea Biffi is a Chairman at Lac2biome S R L, a President & Director at 1lab SA, a Chairman at Sofar Americas, Inc. and an Independent Director at Asensus Surgical, Inc. He is on the Board of Directors at ORION TOPCO LIMITED, Bll Invest SRL, 1lab SA and Asensus Surgical, Inc. Mr. Biffi was previously employed as a President & Chief Executive Officer by Sofar Swiss SA, a Chief Executive Officer & Director by Sofar SpA, and a General Manager by Soveta Baltica Uab.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ASENSUS SURGICAL, INC.
0,73% | 06.06.2023 | 1 974 823 ( 0,73% ) | 454 209 $ | 31.03.2024 |
Aktive Positionen von Andrea Biffi
| Unternehmen | Position | Beginn |
|---|---|---|
| ASENSUS SURGICAL, INC. | Director/Board Member | 21.09.2015 |
Sofar Americas, Inc.
 Sofar Americas, Inc. Pharmaceuticals: MajorHealth Technology Sofar Americas, Inc. manufactures pharmaceutical preparations. The company is headquartered in Petaluma, CA. | Chairman | 01.03.2016 |
1lab SA
 1lab SA Miscellaneous Commercial ServicesCommercial Services Part of 1MED SA, 1lab SA provides advanced preclinical in vitro testing services. The private company is based in Manno, Switzerland. 1lab was acquired by 1MED SA on November 14, 2023. | President | 01.12.2017 |
| Bll Invest SRL | Director/Board Member | 01.10.2018 |
Ehemalige bekannte Positionen von Andrea Biffi
| Unternehmen | Position | Ende |
|---|---|---|
Sofar SpA
 Sofar SpA Miscellaneous Commercial ServicesCommercial Services Sofar SpA manufactures pharmaceutical products, dietary supplements, and medical devices. The firm’s product areas include gastrointestinal, gynecology, dermatology, sleep disorders, pediatric, energy and movement, immune system, beauty and wellness, pregnancy area, weight control, urology, and OTC medications. The company was founded in 1968 and is headquartered in Trezzano Rosa, Italy. | Chief Executive Officer | 01.10.2022 |
| Soveta Baltica Uab | Corporate Officer/Principal | 01.11.2013 |
| Sofar Swiss SA | Chief Executive Officer | 01.11.2013 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASENSUS SURGICAL, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Sofar SpA
Sofar SpA Miscellaneous Commercial ServicesCommercial Services Sofar SpA manufactures pharmaceutical products, dietary supplements, and medical devices. The firm’s product areas include gastrointestinal, gynecology, dermatology, sleep disorders, pediatric, energy and movement, immune system, beauty and wellness, pregnancy area, weight control, urology, and OTC medications. The company was founded in 1968 and is headquartered in Trezzano Rosa, Italy. | Commercial Services |
| Soveta Baltica Uab | |
| Sofar Swiss SA | |
Sofar Americas, Inc.
Sofar Americas, Inc. Pharmaceuticals: MajorHealth Technology Sofar Americas, Inc. manufactures pharmaceutical preparations. The company is headquartered in Petaluma, CA. | Health Technology |
1lab SA
1lab SA Miscellaneous Commercial ServicesCommercial Services Part of 1MED SA, 1lab SA provides advanced preclinical in vitro testing services. The private company is based in Manno, Switzerland. 1lab was acquired by 1MED SA on November 14, 2023. | Commercial Services |
| Bll Invest SRL |
